Evidence map›Paper›PMID 34605979›Full record

ReviewZeitschrift fur Rheumatologie2021

[Digitalization in rheumatological practice].

M Welcker, F Mühlensiepen, J Knitza, F Popp, P Aries

Abstract readReview
In one paragraph

Review in Zeitschrift fur Rheumatologie, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Opportunities and Barriers of Telemedicine in Rheumatology: A Participatory, Mixed-Methods Study.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M WelckerMVZ für Rheumatologie Dr. M. Welcker GmbH, Bahnhofstr. 32, 82152, Planegg, Deutschland. Martin.welcker@rheumatologie-welcker.de.
F MühlensiepenZentrum für Versorgungsforschung, Medizinische Hochschule Brandenburg Theodor Fontane, Rüdersdorf, Deutschland.
J KnitzaMedizinische Klinik 3 - Rheumatologie und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Deutschland.
F PoppMVZ für Rheumatologie Dr. M. Welcker GmbH, Bahnhofstr. 32, 82152, Planegg, Deutschland.
P AriesRheumatologie am Struenseehaus, Hamburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Digitalization in medicine is of major interest since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. This article tries to present the induced changes and technical solutions with respect to the different parts in the patient journey. Symptom checkers, new health applications, digital appointment management etc. are described. Apart from the technical and digital possibilities, the changes in the quality of communication additionally have to be mentioned. There is an urgent need for further technical standardization including the interfaces. In many cases further studies must confirm the equivalence of digital applications in comparison to analogue techniques.

Indexed as

COVID-19Rheumatic DiseasesTelemedicineHumansPandemicsSARS-CoV-2ApplicationsArtificial intelligenceCommunicationDigital devicesTelemedicine

Identifiers

PMID34605979
PMCPMC8488546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.